ABO blood group, hypercoagulability, and cardiovascular and cancer risk

Critical Reviews in Clinical Laboratory Sciences

Volumn 49, Issue 4, 2012, Pages 137-149

  Franchini, Massimo ^a   Favaloro, Emmanuel J ^b   Targher, Giovanni ^c   Lippi, Giuseppe ^d  

^a CARLO POMA HOSPITAL   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

ABO blood group; Bleeding; Cancer; Longevity; Thrombosis; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; BLEEDING; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR RISK; GENOTYPE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MOLECULAR DYNAMICS; NEOPLASM; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; STOMACH CANCER; THROMBOSIS; VEIN THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; CARDIOVASCULAR DISEASES; DISEASE SUSCEPTIBILITY; HEMOSTASIS; HUMANS; NEOPLASMS; RISK FACTORS; THROMBOPHILIA;

EID: 84865518715     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2012.708647     Document Type: Review

References (91)

1. Lowe J. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol 1993;6:465-490.
2. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964;10:238-245.
3. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007;5:14.
4. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001;41:56-60. (Pubitemid 32142246)
5. O'Donnell JS, Lasffan MA. The relationship between ABO histoblood group, factor VIII and von Willebrand factor. Transfus Med 2001;11:343-351.
6. Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all̈ Transfusion 2006;46:1836-1844. (Pubitemid 44435738)
7. Gastineau DA, Moore SB. How important are ABO-related variations in coagulation factor levels Transfusion 2001;41:4-5. (Pubitemid 32142237)
8. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost 1983;50:757.
9. Mohanty D, Ghosh K, Marwaha N, Kaur S, Chauhan AP, Das KC. Major blood group antigens-a determinant of factor VIII levels in blood? Thromb Haemost 1984;51:414.
10. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol 2006;60:144-151. (Pubitemid 44740495)
11. Seltsam A, Hallensleben M, Kollmann A, Rainer Blasczyk R. The nature of diversity and diversification at the ABO locus. Blood 2003;102:3035-3042. (Pubitemid 37248881)
12. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-1695. (Pubitemid 17091627)
13. Souto J, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000;20:2024-2028. (Pubitemid 30644654)
14. Matsui T, Titani K, Mizuochi T. Structures of the asparaginelinked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 1992;267:8723-8731.
15. Sarode R, Goldstein J, Sussman II, Nagel RL, Tsai HM. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor. Br J Haematol 2000;109:857-864. (Pubitemid 30609769)
16. Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977;252:5538-5546. (Pubitemid 8167004)
17. Bronte-Stewart B, Botha MC, Krut LH. ABO blood groups in relation to ischaemic heart disease. Br Med J 1962;1:1646-1650.
18. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969;1:539-542.
19. Westerholm B, Wiechel B, Eklund G. Oral contraceptive, venous thromboembolic disease and AB0 blood type. Lancet 1971;2:664.
20. Mourant AE, Kopec AC, Domamiewska-Sobczak K. Blood groups and blood clotting. Lancet 1971;1:223-227.
21. Jukic I, Bingulac-Popovic J, Dogic V, Babic I, Culej J, Tomicic M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J 2009;50:550-558.
22. Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009;7:263-269.
23. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62-69.
24. Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, et al. ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008;93:729-734. (Pubitemid 351669313)
25. Medalie JH, Levene C, Papier C, Goldbourt U, Dreyfuss F, Oron D, et al. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med 1971;285:1348-1353.
26. Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976;25:311-318.
27. Whincup PH, Cook DG, Phillips AN, Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990;300:1679-1682. (Pubitemid 20202356)
28. Akhund IA, Alvi IA, Ansari AK, Mughal MA, Akhund AA. A study of relationship of ABO blood groups with myocardial infarction and angina pectoris. J Ayub Med Coll Abbottabad 2001;13:25-26.
29. Biancari F, Satta J, Pokela R, Juvonen T. ABO blood group distribution and severity of coronary artery disease among patients undergoing CABG in Northern Finland. Thromb Res 2002;108:195-196. (Pubitemid 36184657)
30. Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Darabian C, Goodarzynejad H. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol 2006;110:256-258. (Pubitemid 43767102)
31. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res 2008;123:200-205.
32. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011;377:383-392.
33. Carpeggiani C, Coceani M, Landi P, Michelassi C, L'abbate A. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010;211:461-466.
34. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994;88:601-607. (Pubitemid 24345110)
35. Suadicani P, Hein HO, Gyntelberg F. Socioeconomic status, ABO phenotypes and risk of ischaemic heart disease: an 8-year follow-up in the Copenhagen Male Study. J Cardiovasc Risk 2000;7:277-283.
36. Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998;79:688-689. (Pubitemid 28120810)
37. Mercier B, Oger E, Le Gal G, Mottier D, Ferec C. Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost 2005;93:388-389. (Pubitemid 40253751)
38. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-155.
39. González Ordóñez AJ, Medina Rodriguez JM, Martín L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis 1999;10:303-307. (Pubitemid 29382672)
40. Robert A, Aillaud MF, Eschwège V, Randrianjohany A, Scarabin Y, Juhan-Vague I. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost 2000;83:630-631. (Pubitemid 30201144)
41. Morelli VM, De Visser MCH, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005;3:183-185. (Pubitemid 41647137)
42. Tirado I, Mateo J, Soria JM, Oliver A, Martínez-Sánchez E, Vallvé C, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005;93:468-474. (Pubitemid 40392534)
43. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007;5:1455-1461. (Pubitemid 46965375)
44. Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 2005;128:100-107.
45. Procare-GEHT Group. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol 2006;135:697-702.
46. Paiva SG, Sabino AP, Carvalho MG, Ribeiro DD, Gomes KB, Santos MS, et al. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis 2009;20:122-128.
47. Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009;113:5298-5303.
48. Larsen TB, Johnsen SP, Gislum M, Moller CA, Larsen H, Sorensen HT. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005;3:300-304. (Pubitemid 41623618)
49. Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJ. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Br J Haematol 2010;149:118-123.
50. Rios DR, Fernandes AP, Carvalho MG, Figueiredo RC, Guimarães DA, Reis DR, et al. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups. Clin Chim Acta 2011;412:425-429.
51. Horwich L, Evans D, McConnell R, Donohoe W. ABO blood groups in gastric bleeding. Gut 1966;7:680-685.
52. Evans D, Horwich L, McConnell R, Bullen M. Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut 1968;9:319-322.
53. Viskum K. Long-term survival of patients with gastrointestinal hemorrhage with special reference to the ABO blood Group. Scand J Gastroenterol 1972;7:55-63.
54. Habbick BF, Melrose AG, Grant JC. Duodenal ulcer in childhood. A study of predisposing factors. Arch Dis Child 1968;43:23-27.
55. Berg M. Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut 1969;10:1029-1030.
56. Bayan K, Tuzun Y, Yilmaz S, Dursun M, Canoruc F. Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci 2009;54:1029-1034.
57. Northfield TC. Factors predisposing to recurrent hemorrhage after acute gastrointestinal bleeding. Br Med J 1971;1:26-28.
58. Daniel M, Jaberoo MC, Stead RE, Reddy VM, Moir AA. Is admission for epistaxis more common in Caucasian than in Asian people? A preliminary study. Clin Otolaryngol 2006;31:386-389. (Pubitemid 44511159)
59. Reddy VM, Daniel M, Bright E, Broad SR, Moir AA. Is there an association between blood group O and epistaxis J Laryngol Otol 2008;122:366-368. (Pubitemid 351501250)
60. Leonard DS, Fenton JE, Hone S. ABO blood type as a risk factor for secondary post-tonsillectomy hemorrhage. Int J Pediatr Otorhinolaryngol 2010;74:729-732.
61. Ionescu DA, Marcu I, Bicescu E. Cerebral thrombosis, cerebral hemorrhage, and ABO blood-groups. Lancet 1976;1:278-280.
62. Larsen S, Antonisen B, Marquardsen J. Cerebral infarction, cerebral hemorrhage and ABO-blood groups. Lancet 1977;1:1064. (Pubitemid 8088715)
63. Welsby IJ, Jones R, Pylman J, Mark JB, Brudney CS, Phillips-Bute B, et al.; for members of Cardiothoracic Anesthesiology Research Endeavours (CARE). Blood Coagul Fibrinolysis 2007;18:781-785.
64. Kuyvenhoven JP, Veenendaal RA, Vanderbroucke JP. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection and the ABO blood group system. Scand J Gastroenterol 1999;34:1082-1086. (Pubitemid 29533765)
65. Halonen P, Linko K, Wirtavuori K, Hastbacka J, Ikkala E. Evaluation of risk factors in intraoperative bleeding tendency. Ann Chir Gynaecol 1987;76:298-302. (Pubitemid 18077879)
66. Garcia AA, van der Heijden JF, Meijers JCM, Rosendaal FR, Reitsma PH. The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 2006;4:1418-1420.
67. Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A; for the SPIRIT Study Group. Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 2007;254:1660-1665.
68. Favaloro EJ. Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost 2011;37:440-455.
69. Castaman G, Eikenboom JC, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999;82:1065-1070. (Pubitemid 29419720)
70. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893-898. (Pubitemid 23353251)
71. Clarke CA. Blood group and disease. In: Steiberg AG, ed. Progress in Medical Genetics. Vol 1. New York, NY: Grune and Stratton, 1961:81-119.
72. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, Nyrén O. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280-1285.
73. Macafee AL. ABO blood groups and carcinoma of pancreas. Ulster Med J 1964;33:129-131.
74. Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatol 1990;6:81-88. (Pubitemid 20248262)
75. Vioque J, Walker AM. Cancer de pancreas y tipologia sanguinea ABO: un estudio de casos y controles. Med Clin (Barc) 1991;96:761-764.
76. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-990.
77. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-431.
78. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502-505.
79. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224-228.
80. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS One 2010;5:e11972.
81. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482-486.
82. Khalili H, Wolpin BM, Huang ES, Giovannucci EL, Kraft P, Fuchs CS, Chan AT. ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1017-1029.
83. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012;130:2129-2137.
84. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. Expression of blood-group antigen A-a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084-1090.
85. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer 2010;46:3345-3350.
86. Wolpin BM, Kraft P, Xu M, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the Pancreatic Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2010;19:3140-3149.
87. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009;29:1958-1967.
88. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAMI-1 levels. Hum Mol Genet 2010;19:1863-1872.
89. Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008;34: 747-761.
90. Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 2011;8:502-512.
91. Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 2010;29:489-496.